Real-time anomaly detection mechanism in biopharma

In such a strictly regulated sphere as biopharma, a single microscopic clothing fiber or tiny glass cracks is not just a defect that leads to batch loss, but a multi-million dollar liability. As patient safety is at stake, the human eye can’t be the gold standard of quality control.

In many cases, even ML (traditional algorithms) can’t address the issue, and biopharma businesses need more sophisticated techs such as computer vision and deep learning for anomaly detection , i.e. cognitive monitoring .

In 2024, the machine vision market was valued at $14.81 billion, and this number is expected to reach $22.59 billion by 2032 , growing at a compound annual growth rate of 8.7%.

What visual anomaly detection in biopharma is, how it works, why its popularity is growing, what benefits this tech brings, and how visual monitoring can be implemented in your particular case — read on to find the answers.

What is real-time anomaly detection in biopharma?

Anomaly detection in the pharmaceutical sector is the process where automated systems identify unusual behavior in biological processes (such as cell growth or protein production) in real time, before the batch is finished. As opposed to traditional methods, where you should wait for lab results for several days to detect failures, real-time visual inspection spots a tiny problem instantly.

Here’s how the whole process looks like:

Real-time anomaly detection: Major benefits

This is a short version of the article published on March 31, 2026. Read the full story on the Aetsoft blog: real-time detection in biopharma